Skip to main content
. 2010 Sep 19;36(6):523–530. doi: 10.1016/j.ijantimicag.2010.07.014

Table 2.

Correlation between consumption of unrestricted antibiotic and the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) infection and the prevalence of MRSA at Chung Shan Medical University Hospital (Taichung, Taiwan), 2001–2009.

ATC code/drug name Antibiotic consumption (DDD/1000 PD)
Spearman correlation coefficients
2001 2002 2003 2004 2005 2006 2007 2008 2009 Incidence of HA-MRSA
Prevalence of MRSA
ρ P-value ρ P-value
J01AA02 Doxycycline 403.83 242.28 308.49 181.70 112.45 119.19 102.69 109.28 130.00 0.686 0.041* 0.483 0.187
J01AA07 Tetracycline 4.20 4.96 0.38 2.42 2.72 1.51 1.80 1.00 0.94 0.084 0.831 −0.017 0.966
J01AA08 Minocycline 101.25 64.32 56.02 18.38 2.09 1.00 1.38 0.96 0.81 0.678 0.045* 0.567 0.112
J01CA01 Ampicillin 7.02 2.19 2.21 0.23 1.16 0.67 4.04 0.14 2.25 0.008 0.983 −0.017 0.966
J01CA04 Amoxicillin 136.49 116.93 207.19 144.17 125.00 122.82 142.34 116.08 107.59 0.619 0.075 0.767 0.016*
J01CA12 Piperacillin 5.35 3.47 0.02 0.00 0.00 0.00 0.01 1.53 0.42 −0.034 0.931 −0.170 0.663
J01CE01 Penicillin G benzathine 1.25 0.91 1.58 1.20 1.01 0.83 0.88 0.81 1.09 0.527 0.145 0.600 0.088
J01CE08 Penicillin G 9.75 5.39 7.66 4.08 2.71 2.54 11.91 3.05 3.32 0.100 0.797 0.150 0.700
J01CF01 Dicloxacillin 118.72 110.12 190.56 101.52 57.64 57.97 58.41 58.79 64.16 0.485 0.185 0.367 0.332
J01CF04 Oxacillin 53.77 51.00 109.39 82.08 73.72 73.31 36.59 55.91 56.03 0.494 0.177 0.600 0.088
J01CF05 Flucloxacillin 0.00 0.00 0.00 0.00 0.00 0.00 36.76 11.68 3.90 −0.785 0.012* −0.584 0.099
J01CR02 Amoxicillin/clavulanic acid 92.20 70.38 212.82 233.87 159.98 131.93 127.28 132.98 131.09 0.268 0.486 0.533 0.139
J01CR04 Sultamicillin tosylate 3.23 13.76 41.18 28.30 19.73 26.88 25.49 30.59 31.26 −0.092 0.814 0.017 0.966
J01DB01 Cefalexin monohydrate 419.89 350.26 630.12 451.57 354.39 314.04 315.64 323.46 328.17 0.561 0.116 0.683 0.042*
J01DB04 Cefazolin 221.54 182.85 300.96 191.03 124.00 114.61 118.21 95.74 67.00 0.795 0.010* 0.783 0.013*
J01DB09 Cefradine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.41 53.90 −0.642 0.062 −0.548 0.127
J01DC04 Cefaclor 42.03 37.26 74.77 57.55 276.97 31.72 42.57 30.92 38.63 0.268 0.486 0.533 0.139
J01DD14 Ceftibuten 0.00 2.64 12.90 22.28 14.64 16.95 21.99 25.85 27.85 −0.686 0.041* −0.483 0.187
J01EC01 Sulfamethoxazole/trimethoprim 129.08 101.29 159.92 89.62 67.91 62.31 67.46 32.30 38.77 0.736 0.024* 0.650 0.058
J01FA01 Erythromycin 93.43 32.27 45.06 8.93 1.95 0.21 0.08 0.00 0.03 0.803 0.009* 0.667 0.050*
J01FA09 Clarithromycin 71.26 68.98 96.34 59.35 32.79 45.34 50.22 62.23 56.39 0.469 0.203 0.367 0.332
J01FA10 Azithromycin 27.35 35.07 80.82 100.09 56.68 33.65 23.59 22.89 19.93 0.661 0.053 0.650 0.058
J01FF01 Clindamycin 113.28 54.23 67.91 33.83 24.15 27.65 25.93 22.79 22.02 0.837 0.005* 0.650 0.058
J01GB03 Gentamicin sulphate 127.23 83.75 127.91 79.49 53.12 45.40 49.29 40.99 31.60 0.770 0.015* 0.700 0.036*
J01XC01 Fusidic acid 7.16 5.23 16.70 14.99 7.87 10.72 10.80 7.64 11.63 0.092 0.814 0.267 0.488
J01XD01 Metronidazole 5.21 4.39 11.38 9.23 8.14 8.37 10.65 9.59 6.57 0.092 0.814 0.333 0.381



Total 2194.53 1643.95 2762.28 1915.93 1580.83 1249.62 1286.02 1233.62 1235.32 0.767 0.016* 0.733 0.025*

ATC, Anatomical Therapeutic Chemical; DDD, defined daily doses; PD, patient-days.

*

P < 0.05 indicates that the 95% confidence interval for the Spearman correlation coefficient (ρ) did not include zero.